Brief: Immunovia Gets Approval To Begin Testing Patients For Pancreatic Cancer With Immray Pancan-D Test
Aug 4 (Reuters) - Immunovia AB (publ) IMMNOV.ST :
* IMMUNOVIA, INC. RECEIVES APPROVAL TO BEGIN TESTING
PATIENTS FOR
PANCREATIC CANCER WITH THE IMMRAY™ PANCAN-D TEST
* THIS APPROVAL WAS RECEIVED FROM MASSACHUSETTS DEPARTMENT
OF
PUBLIC HEALTH ON AUGUST 3, 2021
Source text for Eikon: ID:nWkr413B8k
Further company coverage: IMMNOV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))